A7GG00 AF NFT

Polyribonucleotide nucleotidyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeieokqrh2fcirjll7czsuzpplbemca3ldlfe6gdnvyk73sqxdynvey/metadata.json
IPFS of structure file: 
bafybeideowzgaegjoicbotn7zgr5cyyacilvwwgj7djhjnc4euzyk7wfgq/AF-A7GG00-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7E22357a79b34AeF42307391159609a5C4360249
First NFT owner address (bech32): 
genesis10c3r27nekd9w7s3swwg3t9sf5hzrvqjfamdtq3
Current NFT ID #304154 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
304154
Accession (UniProt):
A7GG00
Name::
Polyribonucleotide nucleotidyltransferase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Langeland / NCTC 10281 / Type F)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A7GG00 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A7GG00|PNP_CLOBL Polyribonucleotide nucleotidyltransferase OS=Clostridium botulinum (strain Langeland / NCTC 10281 / Type F) OX=441772 GN=pnp PE=3 SV=1 MIHTLETTVAGRKMKVDFGKTGMLSNAAIFMSYGDTVVMINANASKEPREGIDFFPLSVDYEERLYSVGKIPGGFIKREGKPSDKSILHARSIDRPLRPLFPNGYRNDVQIVNTVLSVEQDNLPEILAINGSSLALCLSSIPFTTPVAAVSVGLVDGEFIINPTVAQRENTILDLTVCATKERIMMVEAGGQEIDEETMYNAILFGFEECKNIVAFQEEAVAKLGKTKDEQVLYKADEEVEKEVKRFAFDMIKEAMYIMDKDERNAQLDKVKEKISEEFSQKYEDKGADIKEVIYKTQKEIVRNMLLNEDRRPDGRAFDEVRPIGCEVGILPRTHGTGLFTRGLTQVMTVATLGALGDVQILDGIAEEESKRYMHHYNFPSYSVGEVRPLRGPGRREIGHGALAERALEPLIPSQEEFPYTIRLVSEVLSSNGSTSQASVCGSTLALLDAGVPIKRPAAGIAMGLITSDDLEREKVITDIQGIEDFFGDMDFKVAGTEKGITSIQFDTKIKGLSNSCVKDALEGAKKARLHILGKIKECIPEPRKELSKYAPRTEIICIDPEKIRDVIGAGGKVINKIIADTNVKIEIKEDGKIFVTSNNEPEGVKKAISIIEGLTKEVVQGEIYLGKVTKTTNFGAFVEILPGKEGLVHISKLDFARVEKVEDVVSVGDEILVKVTDIDNQGRINLSRKDAIAKKEEEKDK